Drug Database
Back to search

Switzerland· 68684001

Pluvicto 1000 MBq/ml, Injektions-/Infusionslösung

A lutetium (177lu) vipivotide tetraxetan product containing lutetium(177-lu) vipivotidum tetraxetanum, registered in Switzerland by Novartis Pharma Schweiz AG and dispensed under Swissmedic category A. The same ATC class is registered in 9 of our 19 countries.

Cat A (Swissmedic)ATC V10XX05

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedPluvicto 1000 MBq/ml, Injektions-/Inf…ATCV10XX05REGISTER NO.68684001PACKS LISTED0CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about lutetium(177-lu) vipivotidum tetraxetanumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Lutetium (177lu) vipivotide tetraxetan is registered in 9 of 19 countries.

Countries holding a registration under ATC V10XX05 (lutetium (177lu) vipivotide tetraxetan), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 5 of them publish a price we can compare per daily dose
Search lutetium (177lu) vipivotide tetraxetan products by name

Lutetium (177lu) vipivotide tetraxetan · ATC V10XX05

9 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Ireland
  • Netherlands
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Swissmedic (Switzerland)
Active substance
lutetium(177-Lu) vipivotidum tetraxetanum
Manufacturer
Novartis Pharma Schweiz AG
Country
Switzerland (CH)
ATC code
V10XX05
ATC class
Lutetium (177Lu) vipivotide tetraxetan
Defined daily dose
176 MBq, P
Swissmedic category
A
Reimbursed
No
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Lutetium (177lu) vipivotide tetraxetan in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lutetium (177lu) vipivotide tetraxetan products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Pluvicto
  • Liechtenstein · Pluvicto
  • Norway · Pluvicto

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a7294627-a8be-4a08-82b7-5c99d671926c
GET /v1/drugs/a7294627-a8be-4a08-82b7-5c99d671926c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "swissmedic_auth",
  "heilmittelcode": "Radiopharmazeutika"
}
API referenceMCP serverPlans

See everything about lutetium (177lu) vipivotide tetraxetan.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console